SEC Proposes Limiting Rule 15c2-11 to OTC Equity Quotes

The U.S. Securities and Exchange Commission said on 16 March that it wants to amend Exchange Act Rule 15c2-11 so the rule expressly applies only to equity securities. Rule 15c2-11 sets the information-review standard for broker-dealers that publish quotations or maintain a continuous quoted market in over-the-counter securities.

That matters because the rule has long been aimed at curbing manipulation and fraud in OTC equity markets, but firms have also watched closely for how broadly the language could be read across other asset classes. In the SEC’s proposal, Chairman Paul Atkins said the amendment would clarify quotation obligations and confirm what the agency describes as the rule’s original understanding: it is an equity-market rule.

For brokers that make markets or publish prices in OTC names, the proposal does not remove the compliance burden inside equities. Instead, it narrows the perimeter and gives the market a clearer line between equity quotation controls and other products that do not fit the same structure.

Why it matters

For traders, tighter legal scope can reduce uncertainty around where quoting frictions sit in OTC markets. If adopted, the change should help brokers and market makers separate equity-specific review duties from other instruments, which can make quote availability and compliance workflows easier to interpret.

What to watch next

Watch the 60-day comment period after Federal Register publication. The key question is whether the SEC leaves the proposal as a clarification only or receives pressure to revisit broader OTC quotation policy as well.